![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
IMS Health Forecasts Global Pharmaceutical Market Growth of 5-7 Percent in 2011, Reaching $880...
The value of the global pharmaceutical market is expected to grow 5-7 percent in 2011,...
BioMimetic Therapeutics Reports 2010 Third Quarter Earnings Results
BioMimetic Therapeutics, Inc. reported its financial results as of and for the three and nine...
GlaxoSmithKline announced third quarter results-Net Sales growth of 14% compared to the previous quarter
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September...
Bayer lifts sales-Grow by 16.1 percent to EUR 8,581 million
The Bayer Group significantly raised sales and underlying earnings in the third quarter of 2010....
ICON reports revenues of $225 million up 2% on prior year
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device...
Pfizer Entering into a partnership with Laboratorio Teuto Brasileiro S.A to develop and commercialize...
Pfizer Inc. announced that it is entering into a partnership with Laboratorio Teuto Brasileiro S.A.,...
Genzyme Reports Financial Results for the Third-quarter revenue was $1.0 billion,
Genzyme Corp. reported third-quarter earnings growth driven by increased shipments of Cerezyme® (imiglucerase for injection)....
Teva to Report Third Quarter 2010 Financial Results on November 2, 2010
Teva Pharmaceutical Industries Ltd. announced that it will release its third quarter 2010 financial results...
Cephalon Reports Record Sales – Quaterly sales increased 32% percent
Cephalon, Inc. reported second quarter 2010 sales of $712.4 million, a 32 percent increase compared...
Ranbaxy Achieves USD 1 Billion Revenue
The Board of Directors of Ranbaxy Laboratories Limited (RLL) at their meeting held today, took...